Prenatal Testing & Newborn Screening Market By Type 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Prenatal Testing & Newborn Screening Market
Prenatal Testing & Newborn Screening Market: By Type (Screening & Diagnosis Tests); Technology (Tandem Mass Spectroscopy, Electrophoresis, Enzyme And Immuno Assays, DNA Based Assays); Instrument (Hearing Screen, Reagents And Assay Kits, Ultrasonography) - Forecast 2016 - 2021.
Report Code : HCR 0081
Published: 25 March, 2016   No. of pages: 156

  • Report Description
  • Table of Contents
  • Customization Options
Prenatal screening for fetal defects has become a standard part of pregnancy medical care in the past couple of decades. Tests are typically conducted during the first half of pregnancy in order to detect a wide range of genetic and other disorders, and to give women the option of obtaining abortions if in case any defects are diagnosed. While some people believe this as a breakthrough in the prevention or eradications of diseases, it has significantly contributed to the improvement of society as a whole.

Due to the availability of many kinds of tests, parents are currently selecting the safer ones and also the technological developments have generally made the process of testing safe. These tests are also very effective and accurate, with several disorders being detected using single test, thus reducing the need for multiple visits and tests.

The global market for Prenatal testing and newborn screening was estimated to be $XX billion in 2014. The global market for Prenatal testing and new born screening is estimated to grow at a CAGR of XX% and is forecast to reach $XX billion by 2021. Prenatal testing market is forecast to have the highest growth of XX% during the forecast period 2016-2021. Health Care is the major end-user of prenatal testing and newborn screening. North America and Asia alone are estimated to occupy a share of more than XX% during 2016-2021. 



North America is the leading market for prenatal testing and newborn screening with U.S leading the charge. Asia region is forecast to have highest growth in the next few years due to growing adoption of prenatal testing and newborn screening in industrial applications. Asia Prenatal testing and newborn screening market accounts to xx% of the global market. Asia is the fastest growing market followed by Americas.
1. Market Overview
2. Executive Summary
3. Prenatal Testing And Newborn Screening Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Prenatal Testing And Newborn Screening Market-Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
      4.2.1. Power Of Suppliers
      4.2.2. Threats From New Entrants
      4.2.3. Power Of Buyer
      4.2.4. Threat From Substitute Product
      4.2.5. Degree Of Competition
5. Prenatal Testing And Newborn Screening Market-Strategic Analysis
   5.1. Prenatal Testing And Newborn Screening Market - Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product Life Cycle
   5.5. Suppliers And Distributors
   5.6. Swot Analysis
6. Prenatal Testing And Newborn Screening Market By Types
   6.1. Introduction
   6.2. Screening Tests
   6.3. Diagnosis Tests
7. Prenatal Testing And Newborn Screening Market By Diagonising Technique
   7.1. Introduction
   7.2. Non Invasive
      7.2.1. Ultrasonography(Usg)
      7.2.2. Preimplementation Genetic Diagnosis
      7.2.3. Fatel Cells In Maternal Circulation
      7.2.4. Foetus-Free Fetal Dna
   7.3. Invasive
      7.3.1. Amniosentesis
      7.3.2. Cvs
      7.3.3. Fetal Blood Sampling
      7.3.4. Embryoscopy &Fetoscopy
8. Prenatal Testing And Newborn Screening Market By Screening Options
   8.1. Introduction
   8.2. First Trimester
      8.2.1. Nuclear Translucency(Nt)
      8.2.2. Serum Screening
   8.3. Second Trimester
      8.3.1. Triple Screen
      8.3.2. Quadraple Screen
      8.3.3. Genetic Ssonogram
      8.3.4. Extended Sonogram
   8.4. Sequential Screening
   8.5. Ultrasonography
9. Prenatal Testing And Newborn Screening Market Bytechnology
   9.1. Tandem Mass Spectrometry
   9.2. Electrophoresis
   9.3. Enzymes And Immuno Assays
   9.4. Dna Based Assays
   9.5. Pulse Oximetry Technology
   9.6. Hearing Screen Technology
10. Prenatal Testing And Newborn Screening Market By Instruments
   10.1. Hearing Screen Instruments
   10.2. Reagent And Assay Kits
   10.3. Ultrasonography
11. Prenatal Testing And Newborn Screening Market Market-By Geography
   11.1. Americas
      11.1.1. U.S.
      11.1.2. Canada
      11.1.3. Mexico
      11.1.4. Brazil
      11.1.5. Rest Of America
   11.2. Europe
      11.2.1. U.K.
      11.2.2. Germany
      11.2.3. Italy
      11.2.4. France
      11.2.5. Rest Of Europe
   11.3. Asia
      11.3.1. China
      11.3.2. South Korea
      11.3.3. Japan
      11.3.4. India
      11.3.5. Rest Of Apac
   11.4. Rest Of The World (Row)
      11.4.1. Middle East
      11.4.2. Africa
12. Prenatal Testing And Newborn Screening Market Market-Entropy
13. Company Profiles

   13.1. Genetrack Biolabs Inc.
   13.2. Verinata Health, Inc.
   13.3. Lifecodexxag
   13.4. Hoffmann-La Roche Ltd.,
   13.5. Bio-Rad Laboratories
   13.6. Masimo Corporation
   13.7. Perkinelmer Inc.
   13.8. Genquest, Llc.
   13.9. Identity Genetics, Inc.
   13.10. Babycenter, L.L.C.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

14. Appendix
   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports